Prevalence of sarcopenia and relevance of body composition, physiological function, fatigue, and health-related quality of life in patients before allogeneic hematopoietic stem cell transplantation
Supportive Care in Cancer,
Morishita S et al. – Sarcopenia is common in patients before allogeneic hematopoietic stem cell transplant (allo–HSCT) and related to low muscle strength, fatigue, and health–related quality of life (QOL). Male patients may be more susceptible to sarcopenia than female patients before allo–HSCT. Further study of rehabilitation with gender insight is warranted for patients receiving allo–HSCT.